Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126472251 | 12647225 | 1 | I | 20160810 | 20160812 | 20160812 | EXP | FR-ROCHE-1812161 | ROCHE | 49.00 | YR | F | Y | 60.50000 | KG | 20160812 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126472251 | 12647225 | 1 | PS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | U | 50722 | 500 | MG | BID | |||||||
| 126472251 | 12647225 | 2 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | U | 50722 | 250 | MG | BID | |||||||
| 126472251 | 12647225 | 3 | SS | RoValcyte | VALGANCICLOVIR HYDROCHLORIDE | 1 | Oral | U | 21304 | 450 | MG | /wk | |||||||
| 126472251 | 12647225 | 4 | SS | NULOJIX | BELATACEPT | 1 | Intravenous (not otherwise specified) | U | 0 | 300 | MG | ||||||||
| 126472251 | 12647225 | 5 | SS | TRIFLUCAN | FLUCONAZOLE | 1 | Oral | U | 0 | 200 | MG | QD | |||||||
| 126472251 | 12647225 | 6 | SS | AMLOR | AMLODIPINE BESYLATE | 1 | Oral | U | 0 | 10 | MG | QD | |||||||
| 126472251 | 12647225 | 7 | SS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | IN THE EVENING | U | 0 | 40 | MG | QD | ||||||
| 126472251 | 12647225 | 8 | SS | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | BEFORE MEAL TIME | U | 0 | 10 | MG | TID | ||||||
| 126472251 | 12647225 | 9 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | U | 0 | 1 | G | TID | |||||||
| 126472251 | 12647225 | 10 | C | TENORMIN | ATENOLOL | 1 | Oral | 0 | 50 | MG | QD | ||||||||
| 126472251 | 12647225 | 11 | C | SOLUPRED (FRANCE) | PREDNISOLONE | 1 | Oral | 0 | 17.5 | MG | QD | ||||||||
| 126472251 | 12647225 | 12 | C | ARANESP | DARBEPOETIN ALFA | 1 | Subcutaneous | 0 | 100 | UG | QOW | ||||||||
| 126472251 | 12647225 | 13 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | Oral | 0 | 2 | G | TID | ||||||||
| 126472251 | 12647225 | 14 | C | FORLAX | POLYETHYLENE GLYCOL 4000 | 1 | Oral | 0 | 10 | G | QD | ||||||||
| 126472251 | 12647225 | 15 | C | ZOPHREN | ONDANSETRON | 1 | Oral | 0 | 4 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126472251 | 12647225 | 1 | Renal transplant |
| 126472251 | 12647225 | 3 | Product used for unknown indication |
| 126472251 | 12647225 | 4 | Product used for unknown indication |
| 126472251 | 12647225 | 5 | Product used for unknown indication |
| 126472251 | 12647225 | 6 | Product used for unknown indication |
| 126472251 | 12647225 | 7 | Product used for unknown indication |
| 126472251 | 12647225 | 8 | Product used for unknown indication |
| 126472251 | 12647225 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126472251 | 12647225 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126472251 | 12647225 | Agranulocytosis | |
| 126472251 | 12647225 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126472251 | 12647225 | 1 | 20160425 | 0 | ||
| 126472251 | 12647225 | 2 | 20160423 | 0 | ||
| 126472251 | 12647225 | 3 | 20160425 | 0 | ||
| 126472251 | 12647225 | 4 | 20160428 | 20160428 | 0 | |
| 126472251 | 12647225 | 5 | 20160429 | 0 |